Janux Therapeutics, Inc. (JANX)

13.80 -0.03 (-0.22%) USD  |  NASDAQ  |  Dec 31, 16:00
13.74 -0.06 (-0.43%) After-Hours: 20:00
More

Janux Therapeutics Research and Development Expense (TTM): 115.15M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for JANX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 12.56B
Stoke Therapeutics, Inc. 117.76M
Ionis Pharmaceuticals, Inc. 879.75M
MannKind Corp. 49.90M
Madrigal Pharmaceuticals, Inc. 296.43M